Identification |
Name: | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-, (4S)- |
Synonyms: | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-10-nitro-, (S)-;9-Nitro-20(S)-camptothecin;9-Nitrocamptothecin;Orathecin;RFS 2000; |
CAS: | 91421-42-0 |
Molecular Formula: | C20H15N3O6 |
Molecular Weight: | 393.35 |
InChI: | InChI=1S/C20H15N3O6/c1-2-20(26)13-7-16-17-10(8-22(16)18(24)12(13)9-29-19(20)25)6-11-14(21-17)4-3-5-15(11)23(27)28/h3-7,26H,2,8-9H2,1H3/t20-/m1/s1 |
Molecular Structure: |
|
Properties |
Melting Point: | 182-186 oC |
Density: | 1.63g/cm3 |
Appearance: | Yellow amorphous powder |
Storage Temperature: | Room temp |
Usage: | Semisynthetic camptothecin which inhibits DNA topoisomerase I. Prodrug of 9-aminocamptothecin. Antineoplastic |
Safety Data |
|
|